Recombinant Anti-CD20 × Anti-CD3 Bispecific Antibody (CrossMab)

CAT#: CROSS-L025

Recombinant Anti-CD20 × Anti-CD3 Bispecific Antibody (CrossMab) has been generated by applying the Crossmab format to generate an IgG shaped entity that binds each ligand with one arm. This BsAb is capable of targeting the tumor and recruiting T effector cells via binding to the CD3 subunit of the T cell receptor complex. It was designed for the treatment of Non-Hodgkin`s lymphoma and other CD20+ B-cell malignancies.

Specifications

  • Target
  • CD20 & CD3
  • Type
  • CrossMab
  • Species Reactivity
  • Human
  • Target 1
  • CD20
  • Host Species 1
  • Mouse
  • Target 2
  • CD3
  • Host Species 2
  • Mouse
  • Application
  • FuncS, Promising therapeutic agent
  • Related Disease
  • Non-Hodgkin`s lymphoma and other CD20+ B-cell malignancies

Target

  • Target 1
  • CD20
  • Alternative Names
  • MS4A1; membrane-spanning 4-domains, subfamily A, member 1; B1; S7; Bp35; CD20; CVID5; MS4A2; LEU-16; B-lymphocyte antigen CD20; CD20 antigen; CD20 receptor; leukocyte surface antigen Leu-16; B-lymphocyte cell-surface antigen B1
  • Target 2
  • CD3
  • Alternative Names
  • CD3E; CD3e molecule, epsilon (CD3-TCR complex); T3E; TCRE; IMD18; T-cell surface glycoprotein CD3 epsilon chain; CD3-epsilon; T-cell surface antigen T3/Leu-4 epsilon chain; CD3e antigen, epsilon polypeptide (TiT3 complex); T-cell antigen receptor complex, epsilon subunit of T3
REVIEWS AND Q&AS CITATIONS RESOURCES DOWNLOADS RELATED PRODUCTS
Inquiry
Navs

Customer Review

Submit a review or a question

There are currently no Customer reviews or questions for CROSS-L025. Click the button above to contact us or submit your feedback about this product.
Breast cancer biomarkers at key points during disease progression
Robust Cytotoxicity Induction
Our lab used this product to evaluate T cell mediated cytotoxicity against various CD20 positive cell lines. The antibody demonstrated potent activity at low concentrations, and the results were highly reproducible across different donor T cell batches in our experiments.
Breast cancer biomarkers at key points during disease progression
Stable Heterodimer Structure
The structural integrity of this CrossMab is impressive. We performed stability tests over several weeks, and the molecule remained intact without significant degradation. This reliability is crucial for our long-term culture experiments involving blood cancer models.

Q&As

  1. What is the mechanism of action for this bispecific antibody in research?

    A: This product functions by bridging T cells and CD20-expressing tumor cells. One arm binds to the CD20 antigen on B cells, while the other binds to the CD3 subunit of the T cell receptor complex. This physical proximity activates the T cells to exert cytotoxic effects on the target tumor cells.

  2. Does this antibody retain the structure of a standard IgG molecule?

    A: Yes, this bispecific antibody is generated using CrossMab technology to create an IgG-shaped molecule. This design allows it to maintain structural similarities to natural antibodies, potentially offering better stability and pharmacokinetic properties in your research models compared to smaller antibody fragments.

View the frequently asked questions answered by Creative Biolabs Support.

Submit Your Publication

Published with our product? Submit your paper and receive a 10% discount on your next order! Share your research to earn exclusive rewards.

Article title:
DOI/PubMed URL:
Email:
Name:

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Downloadable Resources

Download resources about recombinant antibody development and antibody engineering to boost your research.

Datasheet

MSDS

COA

Certificate of Analysis Lookup

To download a Certificate of Analysis, please enter a lot number in the search box below. Note: Certificate of Analysis not available for kit components.

Lot Number:
Specific Inquiry
Go to compare Add to compare

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Go to compare

Go to compare